Associate Director, Clinical Data Management

Remix Therapeutics is a clinical-stage biopharmaceutical company that has pioneered a new class of small molecule medicines targeting the RNA splicing machinery — correcting the disease-causing errors that drive cancers and other serious conditions at their source.  

REM-422 is our lead program currently focused on developing a therapy for Adenoid Cystic Carcinoma (ACC), a rare cancer for which there is no approved therapy. REM-422 is concurrently being evaluated as a treatment for AML/.HR-MDS with aspirations to evolve into other oncology indications with high unmet need. REM-422 is at a critical inflection point in its clinical development and Remix is building the team to bring this novel molecule forward as a medicine for patients. 

Position Summary:

Remix is seeking a